Literature DB >> 10465088

Quality of life in asymptomatic patients with early HIV infection initiating antiretroviral therapy. Swiss HIV Cohort Study.

C Zinkernagel, B Ledergerber, M Battegay, R W Cone, P Vernazza, B Hirschel, M Opravil.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1999        PMID： 10465088     DOI： 10.1097/00002030-199908200-00024

Source DB:  PubMed          Journal:  AIDS        ISSN： 0269-9370            Impact factor:   4.177


× No keyword cloud information.
  8 in total

1.  Highly active antiretroviral therapy: pharmacoeconomic issues in the management of HIV infection.

Authors:  P Sendi; A J Palmer; A Gafni; M Battegay
Journal:  Pharmacoeconomics       Date:  2001       Impact factor: 4.981

2.  To take or not to take: decision-making about antiretroviral treatment in people living with HIV/AIDS.

Authors:  Heidemarie Kremer; Gail Ironson; Neil Schneiderman; Martin Hautzinger
Journal:  AIDS Patient Care STDS       Date:  2006-05       Impact factor: 5.078

3.  A further investigation of health-related quality of life over time among men with HIV infection in the HAART era.

Authors:  Huanguang Jia; Constance R Uphold; Yu Zheng; Samuel Wu; G John Chen; Kimberly Findley; Pamela W Duncan
Journal:  Qual Life Res       Date:  2007-04-28       Impact factor: 4.147

4.  Quality of life in HIV/AIDS.

Authors:  K H Basavaraj; M A Navya; R Rashmi
Journal:  Indian J Sex Transm Dis AIDS       Date:  2010-07

5.  Cost-effectiveness of genotypic antiretroviral resistance testing in HIV-infected patients with treatment failure.

Authors:  Pedram Sendi; Huldrych F Günthard; Mathew Simcock; Bruno Ledergerber; Jörg Schüpbach; Manuel Battegay
Journal:  PLoS One       Date:  2007-01-24       Impact factor: 3.240

6.  Assessing the effect of HAART on change in quality of life among HIV-infected women.

Authors:  Chenglong Liu; Kathleen Weber; Esther Robison; Zheng Hu; Lisa P Jacobson; Stephen J Gange
Journal:  AIDS Res Ther       Date:  2006-03-20       Impact factor: 2.250

7.  Assessment of quality of life in a cohort of newly diagnosed patients on HAART regimen, in resource restricted tribal region of chhattisgarh, India: a prospective study.

Authors:  Harminder Singh; Kamalpreet Kaur; Navin Dulhani; Akash Bansal; Bithika N Kumar; Vinod Kumar Singh Chouhan
Journal:  J Glob Infect Dis       Date:  2013-07

8.  Comparative analyses of published cost effectiveness models highlight critical considerations which are useful to inform development of new models.

Authors:  T A Rautenberg; G George; M B Bwana; M S Moosa; S Pillay; S M McCluskey; I Aturinda; K Ard; W Muyindike; P Moodley; J Brijkumar; B A Johnson; R T Gandhi; H Sunpath; V C Marconi; M J Siedner
Journal:  J Med Econ       Date:  2020-01-11       Impact factor: 2.448
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.